FDA Cites Procter & Gamble Over Manufacturing Deviations in Children's Toothpaste

The FDA cited Procter & Gamble for deviations from Current Good Manufacturing Practice regulations concerning Crest children's toothpaste production. The FDA classified the products under Class II designation on October 19. More than 4.3 million tubes of toothpaste have been recalled due to manufacturing issues, and Pritam International Private Limited voluntarily recalled products under brands Brush Buddies, evo, and ARU last month.

The citation relates to deviations from Current Good Manufacturing Practice regulations, which outline minimum requirements for manufacturing and processing drug products. The recall involves a large volume of consumer health products, impacting the supply and quality assurance of the market.